Moderna cuts 2025 sales view on slow start to RSV shot, weak COVID vaccine demand
(Reuters) - Moderna (MRNA) cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow launch of ...
Read moreDetails(Reuters) - Moderna (MRNA) cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow launch of ...
Read moreDetails
